Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Saved in:
| Title: | Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine. |
|---|---|
| Authors: | Propper, D J, Braybrooke, J P, Levitt, N C, O’Byrne, K, Christodoulos, K, Han, C, Talbot, D C, Ganesan, T S, Harris, A L |
| Source: | British Journal of Cancer. 6/1/2000, Vol. 82 Issue 11, p1759. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1054/bjoc.2000.1141 |
